DuChemBIO Co.,Ltd. (KOSDAQ:176750)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,550
+150 (1.44%)
At close: Feb 27, 2026
Market Cap299.04B +25.3%
Revenue (ttm)37.25B +7.3%
Net Income7.74B +93.5%
EPS274.60 +83.6%
Shares Out28.34M
PE Ratio38.42
Forward PE17.04
Dividendn/a
Ex-Dividend Daten/a
Volume91,443
Average Volume155,334
Open10,500
Previous Close10,400
Day's Range10,280 - 10,690
52-Week Range8,360 - 14,950
Beta0.03
RSI54.88
Earnings DateMar 20, 2026

About DuChemBIO

DuChemBIO Co.,Ltd. engages in the development, production, and sale of radiopharmaceutical products for cancer diagnosis and treatment in South Korea. Its products include FP-CIT for diagnosis of Parkinson’s disease and Parkinson's syndrome by measuring the density of dopamine transporters present in the brain striatum; F-DOPA for brain tumor diagnosis with neutralization technology; Neuraceq for diagnosis of Alzheimer's disease by measuring the distribution and density of beta amyloid in the brain; and Vizamyl for early diagnosis of beta amylo... [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 2002
Employees 126
Stock Exchange KOSDAQ
Ticker Symbol 176750
Full Company Profile

Financial Performance

Financial Statements